Key result
Lipid droplet proteomics highlights novel diagnostic and therapeutic targets across cardiovascular disease progression.
Answers are grounded in this paper and cite their sources.
This review highlights the importance of characterizing the lipid droplet proteome using omics technologies to better understand their role in cardiovascular diseases and identify potential diagnostic and therapeutic targets.
Lipid droplets (LDs) are cellular dynamic organelles involved in lipid storage and maintaining lipid balance. They contain many proteins on their surface that significantly affect their functions and behaviors. Thus, it becomes crucial to characterize the LD proteome using appropriate "omics" technologies that may contribute to an accurate understanding of the LD roles in human diseases. Indeed, LDs and their associated proteins are involved in several pathologies related to dysfunctional lipid metabolism, such as hyperlipidemia, obesity, metabolic syndrome, and cardiovascular diseases (CVDs). This review aims to provide an overview of "omics" studies focused on characterizing the LD proteome in the cardiovascular field, offering additional insight into the involvement of LDs in the development and progression of heart complications, as well as defining potential targets useful for diagnostic, preventive, and therapeutic approaches for patients.
No takes yet. Share an insight, caveat, or question.
Mallia et al. (2025) conducted a review in Cardiovascular diseases. Lipid droplet proteome characterization was evaluated. Characterization of the lipid droplet proteome using omics technologies offers insights into cardiovascular disease progression and identifies potential diagnostic and therapeutic targets.
Synapse has enriched 10 related papers. Consider them for comparative context: